Clinical trial

Bictegravir in the Elderly Living With HIV (BICEP)

NCT05064020

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2020-08-01

PhaseN/A

Study timeline

Study start (actual)2020-08-01Date precision: day

Registry last updated2024-06-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV-1-infectionunresolved

Interventions

Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]DRUG

Sponsors & collaborators

State University of New York at Buffalolead sponsor

Gilead Sciencescollaborator

Mapped research locations

BuffaloNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05064020 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.